Literature DB >> 10846833

Fatal Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with clonal karyotype abnormality.

E Ito1, J Kitazawa, K Arai, H Otomo, Y Endo, S Imashuku, M Yokoyama.   

Abstract

We report a case of Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (HLH) with clonal karyotype abnormality. A 5-year-old boy was admitted to our hospital with persistent high-grade fever, hepatomegaly, and pancytopenia. Laboratory data disclosed a coagulation abnormality and severe liver damage. Clonal proliferation of EBV-infected cells was detected in the bone marrow by Southern hybridization, and bone marrow cells exhibited clonal chromosomal abnormality. Although the patient was treated with immunochemotherapy according to the HLH94 protocol, the disease recurred during the induction therapy, and the patient died of disseminated intravascular coagulopathy. Considering this aggressive and fatal clinical course, it is important to take intensive therapeutic measures if karyotype abnormality is noted in the treatment of EBV-HLH patients.

Entities:  

Mesh:

Year:  2000        PMID: 10846833

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  6 in total

1.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis.

Authors:  M Yagita; H Iwakura; T Kishimoto; T Okamura; A Kunitomi; R Tabata; Y Konaka; K Kawa
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 3.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Ho-Jin Shin; Joo Seop Chung; Je-Jung Lee; Sang Kyun Sohn; Young Jin Choi; Yeo-Kyeoung Kim; Deok-Hwan Yang; Hyeoung-Joon Kim; Jong Gwang Kim; Young Don Joo; Won Sik Lee; Chang-Hak Sohn; Eun Yup Lee; Goon Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

6.  EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.

Authors:  Mineui Hong; Young Hyeh Ko; Keon Hee Yoo; Hong Hoe Koo; Seok Jin Kim; Won Seog Kim; Heejung Park
Journal:  Korean J Pathol       Date:  2013-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.